Home » Analyst Articles – Company Sum
Analysts’ Recent Ratings Updates for Cleanspark (CLSK)
Cleanspark (NASDAQ: CLSK) has recently received a number of price target changes and ratings updates: 5/22/2026 – Cleanspark was downgraded by Weiss Ratings from “sell (d)” to “sell (d-)”. 5/13/2026 –... More of this article »
Recent Analysts’ Ratings Changes for Keyera (KEYUF)
Several analysts have recently updated their ratings and price targets for Keyera (OTCMKTS: KEYUF): 5/26/2026 – Keyera had its “outperform” rating reaffirmed by Canadian Imperial Bank of Commerce. 5/19/2026 –... More of this article »
Alphabet (GOOG) – Analysts’ Weekly Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of Alphabet (NASDAQ: GOOG) in the last few weeks: 6/2/2026 – Alphabet had its “overweight” rating reaffirmed by Wells Fargo &... More of this article »
Advanced Drainage Systems (WMS) – Analysts’ Recent Ratings Changes
Advanced Drainage Systems (NYSE: WMS) recently received a number of ratings updates from brokerages and research firms: 5/27/2026 – Advanced Drainage Systems was upgraded by Stephens from “equal weight” to “overweight”.... More of this article »
Deckers Outdoor (DECK) – Investment Analysts’ Weekly Ratings Updates
A number of firms have modified their ratings and price targets on shares of Deckers Outdoor (NYSE: DECK) recently: 5/29/2026 – Deckers Outdoor was given a new $128.00 price target by Argus. 5/29/2026 – Deckers Outdoor... More of this article »
Investment Analysts’ Weekly Ratings Changes for Shell (SHEL)
Shell (NYSE: SHEL) recently received a number of ratings updates from brokerages and research firms: 5/25/2026 – Shell was downgraded by Zacks Research from “strong-buy” to “hold”. 5/21/2026 – Shell... More of this article »
Investment Analysts’ Recent Ratings Updates for Hims & Hers Health (HIMS)
A number of firms have modified their ratings and price targets on shares of Hims & Hers Health (NYSE: HIMS) recently: 5/26/2026 – Hims & Hers Health had its price target lowered by Bank of America Corporation from... More of this article »
Global Payments (GPN) – Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of Global Payments (NYSE: GPN) recently: 5/30/2026 – Global Payments was downgraded by Wall Street Zen from “buy” to “hold”. 5/19/2026... More of this article »
Certara (CERT) – Investment Analysts’ Weekly Ratings Changes
Certara (NASDAQ: CERT) recently received a number of ratings updates from brokerages and research firms: 5/29/2026 – Certara had its “sell (e+)” rating reaffirmed by Weiss Ratings. 5/12/2026 – Certara had its... More of this article »
Recent Investment Analysts’ Ratings Updates for Everest Group (EG)
Everest Group (NYSE: EG) has recently received a number of price target changes and ratings updates: 5/22/2026 – Everest Group had its “hold (c)” rating reaffirmed by Weiss Ratings. 5/21/2026 – Everest Group... More of this article »
Dycom Industries (DY) – Analysts’ Recent Ratings Updates
A number of research firms have changed their ratings and price targets for Dycom Industries (NYSE: DY): 6/1/2026 – Dycom Industries had its price target raised by KeyCorp from $482.00 to $610.00. They now have an “overweight”... More of this article »
RS Group (RS1) – Investment Analysts’ Weekly Ratings Updates
A number of firms have modified their ratings and price targets on shares of RS Group (LON: RS1) recently: 5/21/2026 – RS Group had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have... More of this article »
Recent Research Analysts’ Ratings Updates for Cactus (WHD)
A number of firms have modified their ratings and price targets on shares of Cactus (NYSE: WHD) recently: 5/27/2026 – Cactus was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”. 5/20/2026 –... More of this article »
Lexeo Therapeutics (LXEO) – Analysts’ Recent Ratings Changes
Lexeo Therapeutics (NASDAQ: LXEO) has recently received a number of price target changes and ratings updates: 5/29/2026 – Lexeo Therapeutics was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 5/16/2026... More of this article »
Recent Investment Analysts’ Ratings Changes for Enbridge (ENB)
A number of research firms have changed their ratings and price targets for Enbridge (TSE: ENB): 5/26/2026 – Enbridge had its price target raised by TD from C$73.00 to C$79.00. They now have a “hold” rating on the... More of this article »
Recent Investment Analysts’ Ratings Updates for Hiscox (HSX)
Hiscox (LON: HSX) has recently received a number of price target changes and ratings updates: 5/28/2026 – Hiscox had its “add” rating reaffirmed by Peel Hunt. They now have a GBX 1,960 price target on the stock. 5/18/2026... More of this article »
Altius Minerals (ALS) – Investment Analysts’ Weekly Ratings Changes
A number of research firms have changed their ratings and price targets for Altius Minerals (TSE: ALS): 5/14/2026 – Altius Minerals had its price target raised by Raymond James Financial, Inc. from C$52.00 to C$59.00. 5/13/2026... More of this article »
National Vision (EYE) – Analysts’ Recent Ratings Updates
A number of firms have modified their ratings and price targets on shares of National Vision (NASDAQ: EYE) recently: 5/15/2026 – National Vision had its price target lowered by Citigroup Inc. from $40.00 to $39.00. They now... More of this article »
NFI Group (NFI) – Investment Analysts’ Weekly Ratings Changes
A number of research firms have changed their ratings and price targets for NFI Group (TSE: NFI): 5/12/2026 – NFI Group had its price target raised by Stifel Nicolaus from C$25.50 to C$26.00. They now have a “buy”... More of this article »
JAN (JAN) – Research Analysts’ Weekly Ratings Changes
A number of firms have modified their ratings and price targets on shares of JAN (NYSE: JAN) recently: 5/27/2026 – JAN had its price target raised by Scotiabank from $28.00 to $30.00. They now have an “outperform”... More of this article »
Investment Analysts’ Recent Ratings Updates for SAB Biotherapeutics (SABS)
Several brokerages have updated their recommendations and price targets on shares of SAB Biotherapeutics (NASDAQ: SABS) in the last few weeks: 5/22/2026 – SAB Biotherapeutics is now covered by Citigroup Inc.. They set a “buy”... More of this article »
Analysts’ Weekly Ratings Updates for Sandisk (SNDK)
A number of firms have modified their ratings and price targets on shares of Sandisk (NASDAQ: SNDK) recently: 5/29/2026 – Sandisk had its price target raised by Susquehanna from $2,000.00 to $3,250.00. They now have a “positive”... More of this article »
Investment Analysts’ Weekly Ratings Updates for Crinetics Pharmaceuticals (CRNX)
A number of firms have modified their ratings and price targets on shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) recently: 5/17/2026 – Crinetics Pharmaceuticals was upgraded by Wall Street Zen from “strong sell”... More of this article »